2024 Health Care & Life Sciences Top Trends

Driving Tomorrow’s Advances in the Health Care and Life Sciences Ecosystems

April 29, 2024

A pipette dispenses liquid into a petri dish placed over a digital DNA sequencing pattern with colored bars, highlighting the intersection of biotech innovation and intellectual property law.

Artificial intelligence continues to be one of the most talked about business trends. Many of the AI technologies that health care and life sciences companies are adopting are largely untested from a legal perspective, creating gray areas that regulatory agencies are grappling with. AI innovations also offer opportunities for competitive advantage through the strategic management of intellectual property rights.

Telemedicine companies are preparing for heightened regulatory scrutiny of advertising on social media platforms while seeing an overall shift from direct-to-consumer to third-party reimbursement models. On the provider front, established health care systems are increasingly entering into joint ventures with technology-enabled health care platform startups to evolve and innovate.

Pharmaceutical companies are bracing for what could be a sea change in the “deference, supremacy, preemption” paradigm while cosmetics manufacturers are facing increased FDA regulatory requirements under the Modernization of Cosmetics Regulation Act of 2022. The FDA also continues to demonstrate a commitment to expanding diversity in clinical trials with a focus on the recruitment of diverse clinical trial participants.

Foley & Lardner’s 2024 Health Care & Life Sciences Top Trends publication unpacks these and other fast-moving developments to help your business capitalize on opportunities and navigate the potential pitfalls of an uncertain regulatory landscape.

Foley’s Health Care & Life Sciences Sector is comprised of 200+ attorneys with decades of collective in-house experience at health care providers and vendors, pharmaceutical and biotechnology firms, and key state and federal government agencies. Our attorneys have been deeply immersed in these industries, acquiring substantial technical and scientific knowledge through graduate degrees and ongoing training that enables us to provide forward-looking, practical solutions to our clients most pressing business challenges.

The 2024 Health Care & Life Sciences Top Trends Report includes the following articles.

Health Care Litigation: Overview and Assessment of the Impact of Artificial Intelligence
Litigation Trends: How Court Decisions Will Affect Pharmaceutical Manufacturers
Balancing Innovation and Safety: FDA Regulation of AI in Medical Devices
Intellectual Property Strategies for Digital Health AI Companies: Increasing Valuation and Creating Barriers for Competitors
FDA and FTC Poised to Regulate Social Media Advertising of Drugs and Digital Health Services
FDA Regulation of Cosmetics – The Beauty or the Beast
Telemedicine Companies Increasingly Shift from Cash-Only Direct-to-Consumer Models to Third-Party Reimbursement
Diversity in Clinical Trials
Medicare Advantage Marketing Under Pressure
2024 Will Be a Critical Year for the 340B Drug Pricing Program
Health Care Joint Ventures are Heating Up. Here’s What Providers Need to Know

Disclaimer

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.